Brief: Parenteral Drugs India considers erosion of 50 pct of co's peak net worth
Oct 21 (Reuters) - Parenteral Drugs India Ltd PADG.NS
* Considered erosion of 50 percent of peak net worth of co
Source text: http://bit.ly/2e6DmDM
Further company coverage: PADG.NS
(Bengaluru newsroom)
((ReutersIndia.snapping@thomsonreuters.com ;))
Recent news on Parenteral Drugs (India)
See all newsBrief: Parenteral Drugs (India) Ops Remain Closed Due To Labour Unrest
Vinod Kumar Gupta Reappointed MD
Brief: Parenteral Drugs India Gets Shareholders' Nod For Sale Of Shares In Infutec Healthcare
Brief: Parenteral Drugs India Seeks Shareholders' Nod To Transfer Kasrawad, WFI Undertaking
Brief: Parenteral Drugs India To Consider Sale Of Kasrawad Undertaking